Cargando…

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials

INTRODUCTION: We conducted a post-hoc analysis on the effect of recombinant factor VIIa (rFVIIa) on coagulopathic patients from two randomized, placebo-controlled, double-blind trials of rFVIIa as an adjunctive therapy for bleeding in patients with severe trauma. METHODS: Blunt and penetrating traum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizoli, Sandro B, Boffard, Kenneth D, Riou, Bruno, Warren, Brian, Iau, Philip, Kluger, Yoram, Rossaint, Rolf, Tillinger, Michael
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794494/ https://www.ncbi.nlm.nih.gov/pubmed/17184516 http://dx.doi.org/10.1186/cc5133

Ejemplares similares

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) deaths
por: Rossaint, R, et al.
Publicado: (2005)

Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial
por: Kluger, Yoram, et al.
Publicado: (2007)

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
por: Vincent, Jean-Louis, et al.
Publicado: (2006)

Blood transfusion and coagulopathy in geriatric trauma patients
por: Mador, Brett, et al.
Publicado: (2017)

Management of bleeding and coagulopathy following major trauma: an updated European guideline
por: Spahn, Donat R, et al.
Publicado: (2013)

The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
por: Spahn, Donat R., et al.
Publicado: (2019)

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
por: Rossaint, Rolf, et al.
Publicado: (2016)

The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition
por: Rossaint, Rolf, et al.
Publicado: (2023)

Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia
por: Spronk, Henri M. H., et al.
Publicado: (2015)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review
por: Da Luz, Luis Teodoro, et al.
Publicado: (2014)

Trauma-induced coagulopathy and critical bleeding: the role of plasma and platelet transfusion
por: Ishikura, Hiroyasu, et al.
Publicado: (2017)

A systematic review on the rotational thrombelastometry (ROTEM®) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients
por: Veigas, Precilla V., et al.
Publicado: (2016)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant
por: Gandhi, Manish J, et al.
Publicado: (2007)

Recombinant activated coagulation factor VII (rFVIIa) as an adjunctive hemostatic therapy in patients with multiple system organ failure and acute upper gastrointestinal bleeding
por: Milanov, S, et al.
Publicado: (2003)

Management of Coagulopathy in Bleeding Patients
por: Hofer, Stefan, et al.
Publicado: (2021)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
por: Arora, D, et al.
Publicado: (2011)

Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding
por: Chang, Zhi-gang, et al.
Publicado: (2020)

Acute traumatic coagulopathy and trauma-induced coagulopathy: an overview
por: Kushimoto, Shigeki, et al.
Publicado: (2017)

Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma
por: Pusateri, Anthony E, et al.
Publicado: (2005)

Role of Factor VII in Correcting Dilutional Coagulopathy and Reducing Re-operations for Bleeding Following Non-traumatic Major Gastrointestinal and Abdominal Surgery
por: Tsai, Thomas C., et al.
Publicado: (2010)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
por: Abuhasna, Said D., et al.
Publicado: (2012)

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding
por: Habib, Aly Makram
Publicado: (2016)

The shock index for pre-hospital identification of trauma patients with early acute coagulopathy and massive bleeding
por: Pasquier, Pierre, et al.
Publicado: (2015)

Trauma Coagulopathy and Its Outcomes
por: Savioli, Gabriele, et al.
Publicado: (2020)

Prehospital identification of trauma patients with early acute coagulopathy and massive bleeding: results of a prospective non-interventional clinical trial evaluating the Trauma Induced Coagulopathy Clinical Score (TICCS)
por: Tonglet, Martin L, et al.
Publicado: (2014)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
por: Barua, Anupama, et al.
Publicado: (2011)

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
por: Hollis, Allison L., et al.
Publicado: (2016)

The world of trauma working together
por: Rizoli, Sandro, et al.
Publicado: (2012)

Thrombelastography and tromboelastometry in assessing coagulopathy in trauma
por: Johansson, Pär I, et al.
Publicado: (2009)

Tranexamic acid and trauma-induced coagulopathy
por: Nishida, Takeshi, et al.
Publicado: (2017)

Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia
por: ALMAGRO, D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p2skih2rpb4ubvhtnuleeqok5e